DENEI DOLMAN: Open Payments
NPI 1770125700 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 25 payments from 9 companies in 2025. Trend: 2023 $303 · 2024 $405 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 10 | $212 |
| Hologic Sales and Service, LLC | 3 | $159 |
| Astellas Pharma US Inc | 5 | $129 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| Ethicon US, LLC | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Organon LLC | 1 | $21 |
| Baxter Healthcare | 1 | $17 |
Products named: ZURZUVAE, ACESSA PROVU SYSTEM, Veozah, MYFEMBREE, STRATAFIX, GARDASIL 9, ABRYSVO, NEXPLANON.
Industry payments across AZ — which companies pay providers there.
